KLK3 and prostate carcinoma: The PSA test enables invasive prostate cancer to be identified earlier than it might have been diagnosed clinically on the basis of symptoms, but the test also enables the identification of latent tumours that may never have caused symptoms during the man's lifetime (Horwich et al, 1995).